ALERISLIFE INC (ALR) Stock Fundamental Analysis
NASDAQ:ALR - Nasdaq - US33832D2053 - Common Stock - Currency: USD
ALR gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 108 industry peers in the Health Care Providers & Services industry. ALR has a bad profitability rating. Also its financial health evaluation is rather negative. ALR does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
ALR had negative earnings in the past year.
ALR had a negative operating cash flow in the past year.
1.2 Ratios
ALR has negative profitability rations, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ALR has a Gross Margin of 17.07%. This is in the lower half of the industry: ALR underperforms 67.54% of its industry peers.
ALR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.07% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.79%
GM growth 5Y-27.35%
2. Health
2.1 Basic Checks
ALR does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALR has been increased compared to 1 year ago.
Compared to 1 year ago, ALR has a worse debt to assets ratio.
2.2 Solvency
ALR has an Altman-Z score of 0.82. This is a bad value and indicates that ALR is not financially healthy and even has some risk of bankruptcy.
ALR has a Altman-Z score (0.82) which is in line with its industry peers.
ALR has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ALR (0.45) is better than 64.91% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.82 |
ROIC/WACCN/A
WACC7.46%
2.3 Liquidity
A Current Ratio of 1.58 indicates that ALR should not have too much problems paying its short term obligations.
ALR has a better Current ratio (1.58) than 62.28% of its industry peers.
ALR has a Quick Ratio of 1.58. This is a normal value and indicates that ALR is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.58, ALR is doing good in the industry, outperforming 68.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.58 |
3. Growth
3.1 Past
ALR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -141.67%.
The Revenue for ALR has decreased by -31.89% in the past year. This is quite bad
ALR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -7.47% yearly.
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.73%
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-12.4%
Revenue growth 5Y-7.47%
Sales Q2Q%-19.12%
3.2 Future
Based on estimates for the next years, ALR will show a very strong growth in Earnings Per Share. The EPS will grow by 20.52% on average per year.
ALR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -1.08% yearly.
EPS Next Y-29.68%
EPS Next 2Y15.18%
EPS Next 3Y20.52%
EPS Next 5YN/A
Revenue Next Year-23.66%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.08%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALR. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALR's earnings are expected to grow with 20.52% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.18%
EPS Next 3Y20.52%
5. Dividend
5.1 Amount
ALR does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:ALR (3/17/2023, 8:00:00 PM)
1.32
+0.01 (+0.76%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners89.33%
Inst Owner ChangeN/A
Ins Owners2.94%
Ins Owner Change0%
Market Cap44.18M
Analysts45
Price Target1.53 (15.91%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-36.36%
Min EPS beat(2)-40.7%
Max EPS beat(2)-32.01%
EPS beat(4)0
Avg EPS beat(4)-99.82%
Min EPS beat(4)-179.03%
Max EPS beat(4)-32.01%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.83%
Min Revenue beat(2)-5.43%
Max Revenue beat(2)-0.24%
Revenue beat(4)0
Avg Revenue beat(4)-4.43%
Min Revenue beat(4)-7.44%
Max Revenue beat(4)-0.24%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.06 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.29 | ||
| P/tB | 0.29 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.16
EYN/A
EPS(NY)-0.55
Fwd EYN/A
FCF(TTM)-2.07
FCFYN/A
OCF(TTM)-1.61
OCFYN/A
SpS21.15
BVpS4.61
TBVpS4.61
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | N/A | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 17.07% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-40.79%
GM growth 5Y-27.35%
F-Score2
Asset Turnover1.85
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.45 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 122.36% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.58 | ||
| Altman-Z | 0.82 |
F-Score2
WACC7.46%
ROIC/WACCN/A
Cap/Depr(3y)158.12%
Cap/Depr(5y)159.36%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-141.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-22.73%
EPS Next Y-29.68%
EPS Next 2Y15.18%
EPS Next 3Y20.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-31.89%
Revenue growth 3Y-12.4%
Revenue growth 5Y-7.47%
Sales Q2Q%-19.12%
Revenue Next Year-23.66%
Revenue Next 2Y-6.24%
Revenue Next 3Y-1.08%
Revenue Next 5YN/A
EBIT growth 1Y-736.88%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year67.21%
EBIT Next 3Y35.15%
EBIT Next 5YN/A
FCF growth 1Y-137.02%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-114.74%
OCF growth 3YN/A
OCF growth 5YN/A